REVA DAVIS: Open Payments
NPI 1316601115 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 15 payments from 8 companies in 2025. Trend: 2023 $112 · 2024 $29 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $165 |
| Lilly USA, LLC | 4 | $80 |
| Exact Sciences Corporation | 2 | $38 |
| Dexcom, Inc. | 1 | $28 |
| Renalytix AI, Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $23 |
| Corcept Therapeutics | 1 | $23 |
| Optinose US, Inc. | 1 | $18 |
Products named: Ozempic, MOUNJARO, Cologuard Collection Kit, Dexcom G6 Transmitter, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, FREESTYLE LIBRE 3, Korlym, Xhance.
Industry payments across TX — which companies pay providers there.
